Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Agnico Eagle Mines Ltd (AEM) vs Pfizer Inc (PFE) Price & Performance

Agnico Eagle Mines LtdTrade
Pfizer IncTrade

Price performance (Past 24H)

Key statistics

Agnico Eagle Mines Ltd vs Pfizer Inc — how do they compare? Agnico Eagle Mines Ltd trades at $186.95 (market cap $92.01B), while Pfizer Inc trades at $26.41 (market cap $151.73B). The key difference: Pfizer Inc is the larger of the two by market cap, and Pfizer Inc pays the higher dividend (6.46%). Which is the better fit depends on your goals.

AEMPFE
Market Cap
$92.01B$151.73B
Sector
Basic MaterialsHealth
52-Week High
$252.19$28.56
52-Week Low
$130.23$23.60
Enterprise Value
$88.85B$203.22B
Dividend Yield
0.99%6.46%
Volume
29,869,932

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Agnico Eagle Mines Ltd

Agnico Eagle Mines (AEM) trades at $180.48, up 0.93% today, with strong quarterly earnings beats and bullish analyst consensus. The stock shows robust fundamentals with a P/E of 15.56, net income margin of 40.44%, and record free cash flow of $6.82B in 2025. Recent news highlights operational strength amid gold price gains, though cost pressures are noted.

Outlook remains positive with a $219.63 price target and 67.7% buy ratings, supported by organic growth plans. Risks include rising production costs and gold price volatility. The stock offers upside potential but faces margin compression headwinds in 2026.

Pfizer Inc

Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.

The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Agnico Eagle Mines Ltd

Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.

Read more on AEM

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE